未登录

C

Cathee Till

SWOG Statistics and Data Management Center

H指数:28

被引数:2,870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Selenium and Vitamin E Cancer Prevention Trial (SELECT): a secondary, post-intervention analysis on potential excess chronic disease incidence induced by selenium administration

硒和维生素E癌症预防试验（SELECT）：关于硒补充剂可能诱导潜在慢性疾病发病率增加的二次、干预后分析

American Journal of Epidemiology

IF4.8

2026-08-120

OAAI

Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model

评估非那雄胺对血液激肽释放酶标志物水平的影响及转换标志物在四激肽释放酶模型中的应用

European Urology Focus

IF5.6

2026-03-200

PRE

Long-Term Effect Estimation When Combining Clinical Trial and Observational Follow-Up Datasets

当结合临床试验和观察性随访数据集时的长期效应估计

Journal of the American Statistical Association

IF3

2025-08-270

PRE

Health Care Contact Days for Older Adults Enrolled in Cancer Clinical Trials

癌症临床试验中老年受试者的医疗接触日

JAMA NETWORK OPEN

IF9.7

2025-03-130

OA

Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2024-11-192

PRE

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

IF5.1

2024-09-161

PRE

Letter: Survival After Selenium and Vitamin E Supplementation: Long-Term Followup of the Selenium and Vitamin E Cancer Prevention Trial

JOURNAL OF UROLOGY

IF6.8

2024-07-010

PRE

Genetically adjusted PSA levels for prostate cancer screening

NATURE MEDICINE

IF50

2023-06-0132

OAAI

Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2023-03-220

OA

Baseline Insurance and Unplanned Emergency Room Use and Hospitalizations Among Elderly Breast Cancer Patients Participating in Clinical Trials

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2022-09-091

OA

Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-148

OAAI

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms

JNCI CANCER SPECTRUM

IF4.1

2021-10-303

OAAI

When Offered to Participate: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2020-10-06156

OAAI

Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-04-186

OAAI

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims

ARCHIVES OF OSTEOPOROSIS

IF2.8

2019-07-288

OAAI

Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202

IF5.1

2019-03-1215

OAAI

Association between body mass index (BMI) and response to duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS)

CANCER RESEARCH

IF16.6

2019-02-150

PRE

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-08-2939

OAAI

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2018-03-0919

OAAI